ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Diisopropylethylamine → N-Boc-2-Methyl-Piperidine

HRID 366234
印刷

反応式

HRID 366234 の反応式
Cl.CN(C)CCCN=C=NCC.O.ON1C2C=CC=CC=2N=N1.[C:24]([O:28][C:29]([N:31]1[CH2:36][CH2:35][CH:34](C(O)=O)[CH2:33][CH:32]1[CH3:40])=[O:30])([CH3:27])([CH3:26])[CH3:25].N[C@H](CC1C=CC2C(=CC=CC=2)C=1)C(N(C)[C@@H](C1ON=C(C)N=1)CC1C=CC2C(=CC=CC=2)C=1)=O.FC(F)(F)C([O-])=O.C(N(C(C)C)CC)(C)C>CN(C)C=O>[C:24]([O:28][C:29]([N:31]1[CH2:36][CH2:35][CH2:34][CH2:33][CH:32]1[CH3:40])=[O:30])([CH3:27])([CH3:25])[CH3:26]
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 6

HCID 81531DiisopropylethylamineHCID 84468TrifluoroacetateHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 27960291-Hydroxybenzotriazole hydrateHCID 223270181-Boc-2-methylpiperidine-4-carboxylic AcidHCID 53797289
(2R)-2-amino-N-methyl-N-[(1R)-1-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(2-naphthyl)ethyl]-3-(2-naphthyl)propionamide

生成物 1

HCID 4578077N-Boc-2-Methyl-Piperidine

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒2 回

実験手順

N-(3-Dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (0.46 g, 2.42 mmol) and 1-hydroxy-benzotriazole monohydrate(0.37 g, 2.41 mmol) were added to a solution of 2-methylpiperidine-1,4-dicarboxylic acid-1-tert-butylester (0.59 g, 2.42 mmol) in N,N-dimethylformamide (8 mL). After 30 min at 20° C. a solution of (2R)-2-amino-N-methyl-N-[(1R)-1-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(2-naphthyl)ethyl]-3-(2-naphthyl)propionamide (as a trifluoroacetate) (1.0 g, 1.73 mmol) and diisopropylethylamine (0.22 g, 1.73 mmol) in N,N-dimethylformamide (4 mL) was added. After 18 h at 20° C. the reaction mixture was poured on water (100 mL) and extracted several times with ethyl acetate (total 60 mL). The collected organic phases were washed with aqueous citric acid (10%, 20 mL), a saturated solution of sodium hydrogen carbonate (20 mL) and water (3×20 mL). After drying (magnesium sulfate) the solution was concentrated in vacuo to give 1.25 g of crude 4-(1-{methyl-[1-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(2-naphthyl)ethyl]carbamoyl}-2-(2-naphthyl)ethyl)-carbamoyl)-2-methylpiperidine-1-carboxylic acid tert-butyl ester that was used for the next step without further purification.

後処理

  1. additionAfter 18 h at 20° C. the reaction mixture was poured on water (100 mL)
  2. extractionextracted several times with ethyl acetate (total 60 mL)
  3. washThe collected organic phases were washed with aqueous citric acid (10%, 20 mL)
  4. dry with materialAfter drying (magnesium sulfate) the solution
  5. concentrationwas concentrated in vacuo

出典と根拠

ORDレコード
ord-83df415ff17f4abb8b83cb6ef7f61952
出典データセット
uspto-grants-2000_10
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06127391

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート